技術指標
指標
數值
方向
MACD(12,26,9)
0.012
中性
RSI(14)
32.860
中性
STOCH(KDJ)(9,3,3)
38.123
賣出
ATR(14)
0.028
低波動
CCI(14)
-152.743
賣出
Williams %R
76.205
賣出
TRIX(12,20)
-1.387
賣出
StochRSI(14)
0.000
賣出
搜尋
Scinai Immunotherapeutics Ltd
SCNI添加自選
0.238USD
+0.007+3.26%
交易中 （美東）報價延遲15分鐘
824.05K總市值
虧損本益比TTM
關鍵數據
0.230今開
0.270最高
37.19K成交量
虧損本益比TTM
--本益比動
--股利TTM
1.07%換手率
0.230昨收
0.230最低
6.20K成交額
0.17本益比靜
0.33市淨率
0.00%股息率 TTM
-66.26%ROA
6.18052週最高
0.91量比
4.80M淨利潤
3.47M總股本
-3.5600每股盈餘TTM
2.09Beta
-243.39%ROE
0.40752週最低
17.39%振幅
-228.63%毛利率
824.05K總市值
-1.37回報/風險
6.11%風險率
TradingKey Scinai Immunotherapeutics Ltd股票評分
單位: USD 更新時間: 2026-07-24操作建議
Scinai Immunotherapeutics Ltd當前公司基本面數據相對健康，增長潛力較大。當前估值合理，在生物技術與醫療研究行業排名210/386位。機構持股佔比非常高，中期看，股價處於下降通道。近一個月，市場表現較差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Scinai Immunotherapeutics Ltd評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
Scinai Immunotherapeutics Ltd亮點
亮點風險
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
業績增長期
公司處於發展階段，最新年度總收入1.31M美元
利潤高增長
公司淨利潤處於行業前列，最新年度總收入1.31M美元
業績轉虧
公司業績轉虧，最新年度虧損美元
估值低估
公司最新PE估值-0.06，處於3年歷史低位
機構加倉
最新機構持股179.71K股，環比增加15.87%
分析師目標
基於
0
分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
Scinai Immunotherapeutics Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
0.244
賣出
MA10
0.247
賣出
MA20
0.255
賣出
MA50
0.350
賣出
MA100
0.496
賣出
MA200
0.757
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Scinai Immunotherapeutics Ltd簡介
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
公司代碼SCNI
公司Scinai Immunotherapeutics Ltd
CEOReichman (Amir)
網址https://www.scinai.com/
公司股東
相關品種
+0.27%
+1.57%
+0.31%
-0.12%
+0.22%
+1.01%
+0.31%
+1.52%
+1.96%
+0.92%
+1.07%
+0.78%
+2.23%
+1.41%
+1.48%
0.00%
+2.71%
-1.82%
+1.45%
+0.68%熱門品種
52022.900
+122.900 (+0.24%)
27863.600
-286.800 (-1.02%)
7386.600
-21.500 (-0.29%)
15077.000
+129.000 (+0.86%)
63401.000
-818.000 (-1.27%)
6287.700
+23.200 (+0.37%)
82.135
-7.908 (-8.78%)
336.290
+3.270 (+0.98%)
196.435
-10.405 (-5.03%)
4075.220
+22.870 (+0.56%)
常見問題
Scinai Immunotherapeutics Ltd(SCNI)的當前股價是多少？
Scinai Immunotherapeutics Ltd(SCNI)的當前股價是 0.23。
Scinai Immunotherapeutics Ltd 的股票代碼是什麼？
Scinai Immunotherapeutics Ltd的股票代碼是SCNI。
Scinai Immunotherapeutics Ltd股票的52週最高點是多少？
Scinai Immunotherapeutics Ltd股票的52週最高點是6.18。
Scinai Immunotherapeutics Ltd股票的52週最低點是多少？
Scinai Immunotherapeutics Ltd股票的52週最低點是0.41。
Scinai Immunotherapeutics Ltd的市值是多少？
Scinai Immunotherapeutics Ltd的市值是1.19M。
Scinai Immunotherapeutics Ltd(SCNI)股票的每股收益（EPS TTM）是多少
Scinai Immunotherapeutics Ltd(SCNI)股票的每股收益（EPS TTM）是-3.56。